AI Summary16 Sept 20265 Rabiʻ II 1448 AH
AI Summary
16 Sept 20265 Rabiʻ II 1448 AH
ByteDance Secures $290 Million for AI Drug Development Unit
ByteDance has completed a $290 million funding round for its AI drug development unit, following its separation from the main group. Anew Labs achieved a valuation of approximately $1.5 billion after its first external funding round, led by HSG and IDG Capital. The investor list also includes Gaorong Ventures and Primavera Venture Partners, while ByteDance will retain a 56% stake in Anew Labs post-funding.
Follow these topics
Sign in to follow the topics that matter to you
This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.
ByteDance Secures $290 Million for AI Drug Development Unit
ByteDance has completed a $290 million funding round for its AI drug development unit, following its separation from the main group. Anew Labs achieved a valuation of approximately $1.5 billion after its first external funding round, led by HSG and IDG Capital. The investor list also includes Gaorong Ventures and Primavera Venture Partners, while ByteDance will retain a 56% stake in Anew Labs post-funding.
Business
Follow these topics
Sign in to follow the topics that matter to you
This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.
0
0 reading now
Insight Score
Rate to unlock
You have not rated yet.
Sign in to react, rate, and save. Sign In
